Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Critical Examination of Modeling Approaches Used in Economic Evaluations of First-Line Treatments for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: A Systematic Literature Review.
Pharmacoeconomics. 2024 May;42(5):527-568. doi: 10.1007/s40273-024-01362-2. Epub 2024 Mar 15.
Pharmacoeconomics. 2024.
PMID: 38489077
Free PMC article.
Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective.
Kaplan DE, Serper M, Kaushik A, Durkin C, Raad A, El-Moustaid F, Smith N, Yehoshua A.
Kaplan DE, et al. Among authors: raad a.
J Manag Care Spec Pharm. 2022 Oct;28(10):1138-1148. doi: 10.18553/jmcp.2022.28.10.1138.
J Manag Care Spec Pharm. 2022.
PMID: 36125059
Free PMC article.
Item in Clipboard
Integrated vaccination and non-pharmaceutical interventions based strategies in Ontario, Canada, as a case study: a mathematical modelling study.
Betti M, Bragazzi NL, Heffernan JM, Kong J, Raad A.
Betti M, et al. Among authors: raad a.
J R Soc Interface. 2021 Jul;18(180):20210009. doi: 10.1098/rsif.2021.0009. Epub 2021 Jul 14.
J R Soc Interface. 2021.
PMID: 34255985
Free PMC article.
Item in Clipboard
Could a New COVID-19 Mutant Strain Undermine Vaccination Efforts? A Mathematical Modelling Approach for Estimating the Spread of B.1.1.7 Using Ontario, Canada, as a Case Study.
Betti M, Bragazzi N, Heffernan J, Kong J, Raad A.
Betti M, et al. Among authors: raad a.
Vaccines (Basel). 2021 Jun 3;9(6):592. doi: 10.3390/vaccines9060592.
Vaccines (Basel). 2021.
PMID: 34204918
Free PMC article.
Item in Clipboard
Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Unresectable Stage III NSCLC: A US Healthcare Perspective.
Mehra R, Yong C, Seal B, van Keep M, Raad A, Zhang Y.
Mehra R, et al. Among authors: raad a.
J Natl Compr Canc Netw. 2021 Feb 2;19(2):153-162. doi: 10.6004/jnccn.2020.7621. Print 2021 Feb.
J Natl Compr Canc Netw. 2021.
PMID: 33545688
Item in Clipboard
Cite
Cite